Correlation Between Precio Fishbone and Enorama Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Precio Fishbone and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precio Fishbone and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precio Fishbone AB and Enorama Pharma AB, you can compare the effects of market volatilities on Precio Fishbone and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precio Fishbone with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precio Fishbone and Enorama Pharma.

Diversification Opportunities for Precio Fishbone and Enorama Pharma

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Precio and Enorama is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Precio Fishbone AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Precio Fishbone is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precio Fishbone AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Precio Fishbone i.e., Precio Fishbone and Enorama Pharma go up and down completely randomly.

Pair Corralation between Precio Fishbone and Enorama Pharma

Assuming the 90 days trading horizon Precio Fishbone is expected to generate 11.68 times less return on investment than Enorama Pharma. But when comparing it to its historical volatility, Precio Fishbone AB is 3.57 times less risky than Enorama Pharma. It trades about 0.01 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  325.00  in Enorama Pharma AB on September 4, 2024 and sell it today you would lose (9.00) from holding Enorama Pharma AB or give up 2.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Precio Fishbone AB  vs.  Enorama Pharma AB

 Performance 
       Timeline  
Precio Fishbone AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precio Fishbone AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Enorama Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enorama Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Precio Fishbone and Enorama Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Precio Fishbone and Enorama Pharma

The main advantage of trading using opposite Precio Fishbone and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precio Fishbone position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.
The idea behind Precio Fishbone AB and Enorama Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences